Debbie Wake_ Women in Innovation Award

Debbie Wake_女性创新奖

• 批准号: 105125
• 金额: $ 6.37万
• 依托单位: MYWAY DIGITAL HEALTH LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2019
• 资助国家: 英国
• 起止时间: 2019 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=105125
• 关键词: Debbie; Wake_; Women; Innovation; Award

"I am delighted to submit an application for the Women in Innovation Awards. I am a medical doctor/ academic by training, and driven by a passion to 'make a difference'. I hold a strong belief that technology can empower people and improve lives, and have scaled the award winning MyDiabetesMyWay system over 13 years (as clinical lead), to be the only self-management platform in the world to be rolled out nationally (in Scotland) with 40,000 registrants. I have co-founded MyWay Digital Health Ltd (spin out of the University of Dundee), and in 20 months as CEO have 18 employees and secured around £3m in innovation funding, including Innovate UK i) SBRI awards (\> £1m), a ii) Digital Health Catalyst;£1m AI in diabetes care (MyDiabetesIQ) project, iii) NHS Test Bed -NHS Greater Manchester (£400k) and iv) secured NHS England commercial contracts. I believe I have excellent leadership potential and a vehicle to deliver impact through innovationThis application aligns perfectly with the Industrial Grand Challenges around Data and Artificial Intelligence and also to some extend with the Ageing Population strand. I aspire to scale MWDH to be a global leader in data-driven healthcare. In this application, I describe our aspirations to use data and AI to deliver life saving and cost saving solutions for chronic disease management starting with diabetes. This award will give a cash injection supporting the early release and testing of important automated data driven decision support functionality for our MyDiabetesMyWay platform. This will enable us to maintain a competitor advantage. This award will also bring important credibility to the business and support for growth and internationalisation to enable us to reach other market particularly those with very high prevalence of diabetes including the Middle East and US.I am also passionate about enabling women in STEM industries to reach their true potential through role modelling opportunities and keen to enhance my own ongoing learning through the services provided by Innovate Uk and partners."

她说：“我很高兴能申请创新女性奖。我是一名医学博士/受过培训的学者，并被一种“有所作为”的激情所驱使。我坚信技术可以增强人们的能力，改善生活，并在13年的时间里（作为临床负责人）扩展了屡获殊荣的MyDiabetesMyWay系统，成为世界上唯一一个在全国（苏格兰）推出的自我管理平台，拥有40,000名注册者。我与人共同创立了MyWay数字健康有限公司（从邓迪大学剥离出来），在担任首席执行官的20个月里，我拥有18名员工，并获得了大约300万英镑的创新资金，包括Innovate UK I) SBRI奖（100万英镑），a ii)数字健康催化剂；100万英镑用于糖尿病护理人工智能（MyDiabetesIQ）项目，iii) NHS测试平台-NHS大曼彻斯特（40万英镑），iv)获得NHS英格兰商业合同。我相信我有出色的领导潜力和通过创新产生影响的工具。这个应用程序与围绕数据和人工智能的工业大挑战完美地结合在一起，在某种程度上也与人口老龄化相关。我渴望将MWDH扩展为数据驱动型医疗保健领域的全球领导者。在这个应用程序中，我描述了我们的愿望，即使用数据和人工智能为从糖尿病开始的慢性疾病管理提供挽救生命和节省成本的解决方案。该合同将为MyDiabetesMyWay平台的重要自动化数据驱动决策支持功能的早期发布和测试提供资金支持。这将使我们保持竞争优势。该奖项还将为我们的业务带来重要的信誉，并支持我们的增长和国际化，使我们能够进入其他市场，特别是那些糖尿病患病率很高的市场，包括中东和美国。我也热衷于让STEM行业的女性通过榜样机会发挥她们的真正潜力，并热衷于通过Innovate Uk和合作伙伴提供的服务加强我自己的持续学习。”